[Mass spectrometry application for clinical diagnostics chairmen's introductory remarks]

Kuniaki Saito, Fumio Nomura

Research output: Contribution to journalReview articlepeer-review


Mass spectrometry has been recently used in clinical diagnostics, especially drug screening, newborn screening, and bacterial identification; therefore, the current developments in mass spectrometry platforms (i. e. GC-MS, LC-MS/MS) and applications for clinical diagnosis will be discussed. Technological advances in drug analyses and bacterial identification using mass spectrometry during recent years have provided an effective tool for the clinical laboratory. This symposium provides a comprehensive future overview of the latest technologies to quantify metabolites, drugs, and identify bacterial proteins using mass spectrometry, proposed for potential new biomarker development.

Original languageEnglish
Pages (from-to)803-804
Number of pages2
JournalRinsho byori. The Japanese journal of clinical pathology
Issue number9
Publication statusPublished - 01-09-2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of '[Mass spectrometry application for clinical diagnostics chairmen's introductory remarks]'. Together they form a unique fingerprint.

Cite this